The research projects are in the boundaries between chemistry and biology with the goal to develop new therapeutics and to find molecules useful for the study of basic biological processes and mechanisms. Main research topics include photopharmacology, immunotherapy and chemical methods for native protein labelling.
Besides its basic research activities, the group is actively involved in R+D+i industrial projects concerted with companies working mainly in the chemical, pharmaceutical and biosciences fields. MCS provides research support and chemical expertise and advice to academic groups or companies in custom synthesis, process development, medicinal chemistry and analytical methods development.
The PhotoHeart project, supported by “la Caixa” Foundation, aims to provide early and localized treatment after a heart attack to significantly reduce cardiac tissue damage.
Upcoming event: Light switching molecules: Advancing pharmacology for heart and neural diseases.
This R+D+I meeting will bring together researchers, entrepreneurs and the pharma industry interested in photopharmacology research, as well as in the transfer of research results to the market and the development of associated medical devices.
MCS has been accredited as TECNIO centre. This is a certification granted by the Catalan government (Generalitat de Catalunya) which identifies expert technological centers and academic groups involved in applied research in Catalonia, with the aim to promote the transfer of technology from academia to industry to help companies create new products, processes or services.
As part of this certification, we have implemented a Quality Management System to ensure that our services meet our customer’s requirements.
For more information about the TECNIO program, visit its website or watch the promotional video.